Upregulation of K <sub>2P</sub> 3.1 K <sup>+</sup> Current Causes Action Potential Shortening in Patients With Chronic Atrial FibrillationConstanze Schmidt, Dierk Thomas, Niels Voigt et al.|Circulation|2015Cited by 195
Deciphering the pathogenic role of a variant with uncertain significance for short QT and Brugada syndromes using gene‐edited human‐induced pluripotent stem cell‐derived cardiomyocytes and preclinical drug screeningIbrahim El‐Battrawy, Xiaobo Zhou, Andreas Hierlemann et al.|Clinical and Translational Medicine|2021Cited by 22